| 13:30 | Gsk: announces results from 17-year retrospective study on US clinical trial diversity |  |
| 08:18 | MÄRKTE EUROPA/US-chinesische Spannungen und Zinssorgen belasten |  |
| 03/02 | Gsk: morgan stanley cuts target price to 1485p from 1520p… | |
| 02/02 | GSK : le comprimé Jesduvroq approuvé dans l'anémie aux USA |  |
| 02/02 | GSK plc - Benlysta granted Orphan Drug Designation by US FDA for the potential treatmen.. | |
| 02/02 | Tranche Update on Quest Diagnostics Incorporated (N.. | |
| 02/02 | Zahl stationärer Krebsbehandlungen auf tiefstem Stand seit 20 Jahren | |
| 02/02 | Gsk: FY 2022 results transcript | |
| 02/02 | Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in ad.. | |
| 02/02 | Benlysta granted Orphan Drug Designation by US FDA for the potential treatment of syste.. | |
| 02/02 | GSK gets FDA approval for drug to treat anaemia in adults on dialysis | |
| 02/02 | Goldman Sachs cuts Standard Chartered | |
| 02/02 | GSK's Oral Anemia Drug for Dialysis Patients Secures First-in-Class US FDA Nod | |
| 02/02 | GSK plc Announces US Food and Drug Administration Approval of Jesduvroq (Daprodustat), .. | |
| 02/02 | Gsk: Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in .. | |
| 02/02 | U.S. FDA approves GSK's anemia drug for patients on dialysis | |
| 02/02 | U.S. FDA approves new GSK's anemia drug | |
| 02/02 | Quest Diagnostics Incorporated announces an Increase in Equity Buyback | |
| 01/02 | Health Care Up After GSK Earnings -- Health Care Roundup | |
| 01/02 | Analysis-GSK gives few clues on plans to replenish medicine cabinet | |
| 01/02 | Ionis Earns $15 Million Milestone Payment as GSK Advances Bepirovirsen to Phase 3 Studi.. | |
| 01/02 | LATE BRIEFING - Unternehmen und Märkte | |
| 01/02 | FTSE 100 Closes Down 0.1% as Market Awaits Fed -2- | |
| 01/02 | FTSE 100 Closes Down 0.1% as Market Awaits Fed Meeting | |
| 01/02 | Global markets live: AMD, Amgen, Electronic Arts, PayPal, Snap... | |
| 01/02 | MÄRKTE EUROPA/Kleines Plus vor Fed-Entscheid - Software AG schwach | |
| 01/02 | Presse Rundblick - Mittwoch, 1. Februar | |
| 01/02 | MÄRKTE EUROPA/Vorsichtig aufwärts vor Fed-Entscheid - Software AG schwach | |
| 01/02 | GSK's Treatment Candidate for Systemic Sclerosis Gets US FDA's Orphan Drug Designation | |
| 01/02 | Big pharma: GSK beats forecasts, but Novartis lags | |
| 01/02 | GSK : désignation de médicament orphelin de la FDA | |
| 01/02 | Dpa-AFX-Überblick: UNTERNEHMEN vom 01.02.2023 - 15.15 Uhr | |
| 01/02 | GSK plc Declares Fourth Interim Dividend for 2022, Payable on 13 April 2023; Provides D.. | |
| 01/02 | Tesco Could Make Further Acquisitions Given -2- | |
| 01/02 | Tesco Could Make Further Acquisitions Given Robust Free Cash Flow | |
| 01/02 | Wall Street attend la Fed, l'Europe profite du ralentissement de l'inflation | |
| 01/02 | Point marchés-Wall Street attend la Fed, l'Europe profite du ralentissement de l'inflat.. | |
| 01/02 | Fed Policy Announcement Eyed as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Wed.. | |
| 01/02 | MIDDAY BRIEFING - Unternehmen und Märkte | |
| 01/02 | MÄRKTE EUROPA/Vor Zinsentscheidungen abwartend - Software AG schwach | |
| 01/02 | Trending : GSK 4Q Earnings, Sales Beat Expectations | |
| 01/02 | European Midday Briefing: Investors Eye Fed Decision | |
| 01/02 | Vodafone's Europe woes, Darktrace in trouble: Marke.. | |
| 01/02 | Restructuration pour Orpéa, record absolu pour Exxo.. | |
| 01/02 | Sterling Should Rise if BOE Lifts Rates By 50Bp, Will Fall Sharply on 25Bp Increase | |
| 01/02 | GSK's Q4 Adjusted Earnings, Sales Increase; Issues 2023 Outlook | |
| 01/02 | Glaxo: Q4 Earnings Snapshot | |
| 01/02 | GSK: bénéfice 2022 dopé par la scission des soins grand public | |
| 01/02 | Stocks to Watch in Europe: GSK, Novartis, Novo Nordisk, BBVA, .. | |
| 01/02 | GSK : 4ème trimestre meilleur que prévu, confiance pour 2023 | |
| 01/02 | British Drugmaker GSK Upbeat on 2023 Prospects Amid Expected Vaccines Boost | |
| 01/02 | GSK profit up; Vodafone growth slows; US Fed ahead | |
| 01/02 | Les marchés retiennent leur souffle, la Fed sous les projecteurs | |
| 01/02 | GSK profit grows as aims for first-ever approved RSV vaccine | |
| 01/02 | FTSE 100 Rises as Entain, Halma Rally | |
| 01/02 | Pharmakonzern GSK bleibt dank Impfstoffgeschäft optimistisch für 2023 | |
| 01/02 | GSK fait mieux que prévu au quatrième trimestre | |
| 01/02 | L'optimisme de retour en Europe avant l'inflation et la Fed | |
| 01/02 | GSK profitiert von hoher Nachfrage nach Gürtelrose-Impfstoff | |
| 01/02 | GSK: bénéfice 2022 plus que triplé à 15 milliards de livres | |
| 01/02 | Sterling Faces Sustained Weakness on UK Growth Concerns | |
| 01/02 | L'optimisme de retour en Europe avant l'inflation et la Fed | |
| 01/02 | GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines -- Update | |
| 01/02 | GSK mit kräftigem Gewinnanstieg im Schlussquartal | |
| 01/02 | Gsk: FY 2022 results slides | |
| 01/02 | Gsk gagne 1,1% après la publication de ses résultats trimestriels | |
| 01/02 | CORRECT: Stocks open higher ahead of US Fed rate decision | |
| 01/02 | Pas de blague, hein ? | |
| 01/02 | GSK boekt minder kwartaalomzet |  |
| 01/02 | Stocks called higher ahead of US Fed rate decision | |
| 01/02 | GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines | |
| 01/02 | CAC 40 : des prises d'initiative limitées avant la Fed | |
| 01/02 | British Drugmaker GSK's FY22 Profit Tops Estimates Amid Record Shingrix Sales | |
| 01/02 | US FDA Grants Orphan Drug Designation to GSK's Systemic Sclerosis Treatment | |
| 01/02 | En Direct des Marchés : Airbus, Orpea, Derichebourg, Bonduelle, GS.. | |
| 01/02 | Gsk - gsk expects turnover and adjusted operating profit gro… | |
| 01/02 | Gsk - 2023 guidance at cer and excludes any contribution fro… | |
| 01/02 | Gsk - 2023 turnover expected to increase between 6% to 8%… | |
| 01/02 | Gsk - 2023 adjusted operating profit expected to increase be… | |
| 01/02 | Gsk plc - final results… | |
| 01/02 | Gsk - 13.75p dividend declared for q4 2022. no change to exp… | |
| 01/02 | Gsk- fy (not qtrly) covid-19 solutions (xevudy) sales… | |
| 01/02 | GSK reports Q4 profit, sales beat Wall Street estimates | |
| 01/02 | Gsk: 2022 ESG updates at a glance | |
| 01/02 | Gsk: FY 2022 results infographic | |
| 01/02 | GSK Says Benlysta Granted Orphan Drug Designation By FDA | |
| 01/02 | GSK reports Q4 profit, sales beat Wall Street estimates | |
| 01/02 | Gsk: delivers strong 2022 performance with full year sales of £29.3 billion +19% AER, +13.. | |
| 01/02 | Earnings Flash (GSK.L) GSK Posts FY22 Revenue GBP29.32B | |
| 01/02 | Earnings Flash (GSK.L) GSK Reports FY22 EPS GBX109.2 | |
| 01/02 | BOLETÍN MATINAL: 1 de febrero de 2023 |  |
| 01/02 | GSK plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31.. | |
| 01/02 | GSK plc Provides Earnings Guidance for the Full Year 2023 | |
| 01/02 | Point marchés-Hausse en vue en Europe avec l'espoir d'une accalmie sur les taux de la F.. | |
| 01/02 | Stocks called up as all eyes on Fed decision | |
| 01/02 | Dax vor Fed-Entscheid zur Eröffnung höher erwartet | |
| 01/02 | MORNING BRIEFING - Deutschland/Europa | |
| 01/02 | Marketmind: Lights, camera, action | |
| 01/02 | EMEA Morning Briefing: Stocks Poised for a Mixed Start Ahead of Fed Decision | |
| 01/02 | TAGESVORSCHAU/Mittwoch, 1. Februar | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
